IgM-Anticardiolipin Antibody and Vascular Access Thrombosis in Chronic Hemodialysis Patients

References

• Adler, S.; Szczech, L.; Qureshi, A.; Bollu, R.; ThomasJohn, R. IgM anticardiolipin antibodies are associated with stenosis of vascular access in hemodialysis patients but do not predict thrombosis. Clin. Nephrol. 2001, 56, 428–434. [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Haviv, Y S. Association of anticardiolipin antibodies with vascular access occlusion in hemodialysis patients: cause or effect? Nephron 2000, 86, 447–454. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Gronhagen-Riska, C.; Teppo, A M.; Helentera, A.; Honkanen, E.; Julkunen, H. Raised concentration of antibodies to cardiolipin in patients receiving dialysis. B.M.J. 1990, 300, 1696–1697.
   PubMedGoogle Scholar
• Valeri, A.; Joseph, R.; Radhakrishnan, J. A large prospective survey of anti-cardiolipin antibodies in chronic hemodialysis patients. Clin. Nephrol. 1999, 51, 116–121. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Prakash, R.; Miller, C C.; Suki, W N. Anticardiolipin antibody in patients on maintenance hemodialysis and its association with recurrent arteriovenous graft thrombosis. Am. J. Kidney Dis. 1995, 26, 347–352. [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Manns, B J.; Burgess, E D.; Parsons, H G.; Schaefer, J P.; Hyndman, M E.; Scott-Douglas, N W. Hyperhomocystinemia, anticardiolipin antibody status, and risk for vascular access thrombosis in hemodialysis patients. Kidney Int. 1999, 55, 315–320. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Page, B.; Yazbeck, F.; Zingraff, J.; Zins, B.; Bourquelot, P. Clotting of vascular access in dialysis patients associated to anticardiolipin antibodies. Nephrol. Dial. Transplant. 1992, 7, 733 (abstr).
   Google Scholar
• Garcia-Martin, F.; De Arriba, G.; Carrascosa, T.; Moldenhauer, F.; Martin-Escobar, E.; Val, J.; Saiz, F. Anticardiolipin antibodies and lupus anticoagulant in end-stage renal disease. Nephrol. Dial. Transplant. 1991, 6, 543–547. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Chew, S L.; Lins, R L.; Daelemans, R.; Zachee, P.; De Clerck, L S.; Vermylen, J. Are anticardiolipin antibodies clinically relevant in dialysis patients? Nephrol. Dial. Transplant. 1992; 14, 1194–1198.
   Google Scholar
• Sitter, T.; Schiffl, H. Anticardiolipin antibodies in patients on regular hemodialysis: an epiphenomenon?. Nephron 1993, 64, 655–656 (letter). [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Cockwell, P.; Tse, W Y.; Savage, C O. Activation of endothelial cells in thrombosis and vasculitis. Scand. J. Rheumatol. 1997, 26, 145–150. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Prieto, L N.; Suki, W N. Frequent hemodialysis graft thrombosis: association with antiphospholipid antibodies. Am. J. Kidney Dis. 1994, 23, 587–590. [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Brunet, P.; Aillaud, M F.; San Marco, M.; Philip-Joet, C.; Dussol, B.; Bernard, D.; Juhan-Vague, I.; Berland, Y. Antiphospholipid on hemodialysis patients: relationship between lupus anticoagulant and thrombosis. Kidney Int. 1995, 48, 794–800. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Sitter, T.; Spannagl, M.; Schiffl, H. Anticardiolipin antibodies and lupus anticoagulant in patients treated with different methods of renal replacement therapy in comparison to patients with systemic lupus erythematosus. Ann. Hematol. 1992, 65, 79–82. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Sebastiani, G D.; Galeazzi, M.; Tincani, A.; Piette, J C.; Font, J.; Allergi, F.; Mathieu, A.; Smolen, J.; De Ramon Garrido, E.; Fernandez-Nebro, A.; Jedryka-Goral, A.; Papasteriades, C.; Morozzi, G.; Bellisai, F.; De Pita, O.; Marcolongo, R. Anticardiolipin and antibeta2 GP1 antibodies in a large series of European patients with systemic lupus erythematosus. Prevalence and clinical associations. Scand. J. Rheumatol. 1999, 28, 344–351. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Fabrizi, F.; Sangiorgio, R.; Pontoriero, G.; Corti, M.; Tentori, F.; Troina, E.; Locatelli, F. Antiphospholipid (aPL) antibodies in end-stage renal disease. J. Nephrol. 1999, 12, 89–94. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Cervera, R.; Font, J.; Lopez-Soto, A.; Casals, F.; Pallares, L.; Bove, A.; Ingelmo, M. Systemic lupus erythematosus: prospective analysis of a series of 100 patients. Ann. Rheum. Dis. 1990, 49, 109–113. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Love, P E.; Santoro, S A. Antiphospholipid antibodies: anticardiolipid and the lupus anticoagulantin systemic lupus erythematosus (SLE) and non-SLE disorders. Ann. Intern. Med. 1990, 112, 682–698. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Cheung, A K.; Dalpias, D.; Emmerson, R.; Leypoldt, J K. A prospective study on intradialytic symptoms associated with reuse of hemodialyzers. Am. J. Nephrol. 1991, 11, >397–401. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Matsuda, J.; Saitoh, N.; Gotoh, M.; Gohchi, K.; Tsukamoto, M.; Syoji, S.; Miyake, K.; Yamanaka, M. High prevalence of anti-phospholipid antibodies and anti-thyroglobulin antibody in patients with hepatitis C virus infection treated with interferon-alpha. Am. J. Gastroenterol. 1995, 90, 1138–1141. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Dalekos, G N.; Kistis, K G.; Boumba, D S.; Voulgari, P.; Zervou, E K.; Drosos, A A.; Tsianos, E V. Increase anti-cardiolipin antibodies in patients with hepatitis C is not associated with etiopathogenetic link to anti-phospholipid syndrome. Eur. J. Gastroenterol. Hepatol. 2000, 12, 67–74. [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Zachou, K.; Liaskos, C.; Christodoulou, D K.; Kardasi, M.; Papadamou, G.; Gatselis, N.; Georgiadou, S P.; Tsianos, E V.; Dalekos, G N. Anti-cardiolipin antibodies in patients with chronic viral hepatitis are independent of beta2-glycoprotein I cofactor or features of antiphospholipid syndrome. Eur. J. Clin. Invest. 2003, 33, 161–168. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar